TSS
MCRB icon

Two Sigma Securities’s Seres Therapeutics MCRB Stock Holding History

Two Sigma Securities’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,279
Closed -$17.9K – 1845
2025
Q1 		$17.9K Buy
+1,279
New +$20K ﹤0.01% 1121
2024
Q3 		– Sell
-2,122
Closed -$30.7K – 3332
2024
Q2 		$30.7K Buy
2,122
+1,078
+103% +$18K ﹤0.01% 2635
2024
Q1 		$16.2K Buy
+1,044
New +$22.5K ﹤0.01% 2698
2023
Q1 		– Sell
-557
Closed -$62.4K – 3024
2022
Q4 		$62.4K Buy
+557
New +$74.7K ﹤0.01% 2128

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Two Sigma Securities's MCRB Position: Q2 2025 in Review

Two Sigma Securities sold out of Seres Therapeutics (MCRB) in Q2 2025, closing a stake of 1,279 shares — an estimated $17.9K sold.

Two Sigma Securities first reported a position in MCRB in Q4 2022 and held it in 4 quarters. The position peaked at $62.4K in Q4 2022. 33 funds tracked by Wall St. Rank hold MCRB as of Q2 2025.

  • Two Sigma Securities reported no remaining Seres Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Securities sold 1,279 Seres Therapeutics shares in Q2 2025, an estimated $17.9K.
  • Two Sigma Securities first reported a position in Seres Therapeutics in Q4 2022 and held it in 4 quarters.
  • Two Sigma Securities's Seres Therapeutics position peaked at $62.4K in Q4 2022.
  • 33 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.